The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 6th 2024
The rheumatology month in review emphasizes new trends in medication use and novel technologies' potential for managing fibromyalgia.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
For Menopausal Patients: Taking an Active Stand Against Osteoporosis
May 13th 2011Osteoporosis is a disease in which the bones lose their content of minerals, particularly calcium. When this occurs, the bones become weakened an prone to fracture. Common sites of fracture include the spine, hip, ribs, and wrist.
Psoriatic Arthritis: Expanding Therapeutic Options
May 2nd 2011The therapeutic options for psoriatic arthritis (PsA) have expanded rapidly and improved patients’ pain, function, and quality of life. However, many patients do not respond to the current disease-modifying medications or cannot take them. Oral methotrexate is the leading disease-modifying antirheumatic drug used in PsA.
Juvenile Arthritis Guidelines Focus on Multiple Medications
April 30th 2011Clinical guidelines for the management of juvenile idiopathic arthritis (JIA) recently released by the American College of Rheumatology (ACR) focus on the initiation and safety monitoring of treatment with multiple medications.
Lifetime Risk of RA Higher Than Previously Thought
April 30th 2011The lifetime risk of inflammatory autoimmune rheumatologic disease is substantial-1 in 12 for women and 1 in 20 for men, and the lifetime risk of rheumatoid arthritis (RA)-1 in 28 for women and 1 in 59 for men-is higher than previously thought.
Differentiating Lyme Arthritis From Septic Arthritis: Clues Uncovered
April 29th 2011The prevalence of Lyme arthritis is high in pediatric patients who present with joint effusions in an area of the Northeastern United States in which the disease is endemic, and the disease is more common than septic arthritis.
Lupus Medication Trends: Immunosuppressives and Prednisone Linked With Disease Activity and Damage
April 29th 2011Treatment for systemic lupus erythematosus (SLE) with both immunosuppressive agents and prednisone is given to patients who have the most active disease, but the presence of cumulative damage also may predict use of these agents, particularly early in the disease course.